Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.

Sequential treatment with endocrine or chemotherapy is generally used in the treatment of estrogen receptor (ER)-positive recurrent breast cancer. To date, few studies have investigated the effect of long-term endocrine therapy on the response to subsequent chemotherapy in ER-positive breast cancer....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Takayuki Watanabe, Takaaki Oba, Keiji Tanimoto, Tomohiro Shibata, Shinobu Kamijo, Ken-Ichi Ito
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/5362605a848c460bb25cd70fbbc06aa8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!